These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 9229019)

  • 21. Plasmodium falciparum CS C-terminal fragment: preclinical evaluation and phase I clinical studies.
    Roggero MA; Weilenmann C; Bonelo A; Audran R; Renggli J; Spertini F; Corradin G; López JA
    Parassitologia; 1999 Sep; 41(1-3):421-4. PubMed ID: 10697896
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heterologous prime-boost immunization in rhesus macaques by two, optimally spaced particle-mediated epidermal deliveries of Plasmodium falciparum circumsporozoite protein-encoding DNA, followed by intramuscular RTS,S/AS02A.
    Walsh DS; Gettayacamin M; Leitner WW; Lyon JA; Stewart VA; Marit G; Pichyangkul S; Gosi P; Tongtawe P; Kester KE; Holland CA; Kolodny N; Cohen J; Voss G; Ballou WR; Heppner DG
    Vaccine; 2006 May; 24(19):4167-78. PubMed ID: 16574282
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A malaria T-cell epitope recognized in association with most mouse and human MHC class II molecules.
    Sinigaglia F; Guttinger M; Kilgus J; Doran DM; Matile H; Etlinger H; Trzeciak A; Gillessen D; Pink JR
    Nature; 1988 Dec 22-29; 336(6201):778-80. PubMed ID: 2462673
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nonpolymorphic regions of p190, a protein of the Plasmodium falciparum erythrocytic stage, contain both T and B cell epitopes.
    Sinigaglia F; Takacs B; Jacot H; Matile H; Pink JR; Crisanti A; Bujard H
    J Immunol; 1988 May; 140(10):3568-72. PubMed ID: 2452192
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recognition of synthetic 104-mer and 102-mer peptides corresponding to N- and C-terminal nonrepeat regions of the Plasmodium falciparum circumsporozoite protein by sera from human donors.
    Lopez JA; Roggero MA; Duombo O; Gonzalez JM; Tolle R; Koita O; Arevalo-Herrera M; Herrera S; Corradin G
    Am J Trop Med Hyg; 1996 Oct; 55(4):424-9. PubMed ID: 8916800
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of human T cell clones specific for conserved peptide sequences within malaria proteins. Paucity of clones responsive to intact parasites.
    Quakyi IA; Currier J; Fell A; Taylor DW; Roberts T; Houghten RA; England RD; Berzofsky JA; Miller LH; Good MF
    J Immunol; 1994 Sep; 153(5):2082-92. PubMed ID: 8051413
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low CD8+ T lymphocyte response to P. falciparum circumsporozoite protein in naturally-exposed malaria endemic populations in Thailand.
    Khusmith S; Tangteerawatana P; Looareesuwan S
    Southeast Asian J Trop Med Public Health; 1999 Sep; 30(3):405-11. PubMed ID: 10774643
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human T cell recognition of polymorphic epitopes from malaria circumsporozoite protein.
    de Groot AS; Johnson AH; Maloy WL; Quakyi IA; Riley EM; Menon A; Banks SM; Berzofsky JA; Good MF
    J Immunol; 1989 Jun; 142(11):4000-5. PubMed ID: 2469729
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of two long synthetic merozoite surface protein 2 peptides as malaria vaccine candidates.
    Flueck C; Frank G; Smith T; Jafarshad A; Nebie I; Sirima SB; Olugbile S; Alonso P; Tanner M; Druilhe P; Felger I; Corradin G
    Vaccine; 2009 May; 27(20):2653-61. PubMed ID: 19428875
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CD4 T cell responses to a variant antigen of the malaria parasite Plasmodium falciparum, erythrocyte membrane protein-1, in individuals living in malaria-endemic areas.
    Allsopp CE; Sanni LA; Reubsaet L; Ndungu F; Newbold C; Mwangi T; Marsh K; Langhorne J
    J Infect Dis; 2002 Mar; 185(6):812-9. PubMed ID: 11920299
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human recognition of T cell epitopes on the Plasmodium vivax circumsporozoite protein.
    Herrera S; Escobar P; de Plata C; Avila GI; Corradin G; Herrera MA
    J Immunol; 1992 Jun; 148(12):3986-90. PubMed ID: 1376347
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunogenicity of multiple antigen peptides containing B and non-repeat T cell epitopes of the circumsporozoite protein of Plasmodium falciparum.
    Calvo-Calle JM; de Oliveira GA; Clavijo P; Maracic M; Tam JP; Lu YA; Nardin EH; Nussenzweig RS; Cochrane AH
    J Immunol; 1993 Feb; 150(4):1403-12. PubMed ID: 7679427
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasmodium falciparum merozoite surface protein 2: epitope mapping and fine specificity of human antibody response against non-polymorphic domains.
    Balam S; Olugbile S; Servis C; Diakité M; D'Alessandro A; Frank G; Moret R; Nebie I; Tanner M; Felger I; Smith T; Kajava AV; Spertini F; Corradin G
    Malar J; 2014 Dec; 13():510. PubMed ID: 25526742
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structural and immunological analysis of circumsporozoite protein peptides: a further step in the identification of potential components of a minimal subunit-based, chemically synthesised antimalarial vaccine.
    Bermúdez A; Vanegas M; Patarroyo ME
    Vaccine; 2008 Dec; 26(52):6908-18. PubMed ID: 18930095
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibody response profiles induced by Plasmodium falciparum glutamate-rich protein in naturally exposed individuals from a Brazilian area endemic for malaria.
    Pratt-Riccio LR; Lima-Junior JC; Carvalho LJ; Theisen M; Espíndola-Mendes EC; Santos F; Oliveira-Ferreira J; Goldberg AC; Daniel-Ribeiro CT; Banic DM
    Am J Trop Med Hyg; 2005 Dec; 73(6):1096-103. PubMed ID: 16354819
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasmodium falciparum: sequence diversity and antibody recognition of the Merozoite surface protein-2 (MSP-2) in Brazilian Amazonia.
    Tonon AP; Hoffmann EH; Silveira LA; Ribeiro AG; Gonçalves CR; Ribolla PE; Wunderlich G; Ferreira MU
    Exp Parasitol; 2004; 108(3-4):114-25. PubMed ID: 15582508
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The human immune response against the major merozoite surface antigen of Plasmodium falciparum.
    Crisanti A; Müller HM
    Parassitologia; 1991 Apr; 33(1):71-7. PubMed ID: 1841197
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthetic peptides from P. falciparum sexual stage 25-kDa protein induce antibodies that react with the native protein: the role of IL-2 and conformational structure on immunogenicity of Pfs25.
    Quakyi IA; Miller LH; Good MF; Ahlers JD; Isaacs SN; Nunberg JH; Houghten RA; Keister DB; Coligan JE; Moss B
    Pept Res; 1995; 8(6):335-44. PubMed ID: 8838417
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of a conserved region of Plasmodium falciparum MSP3 targeted by biologically active antibodies to improve vaccine design.
    Singh S; Soe S; Mejia JP; Roussilhon C; Theisen M; Corradin G; Druilhe P
    J Infect Dis; 2004 Sep; 190(5):1010-8. PubMed ID: 15295710
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Correlation of high levels of antibodies to multiple pre-erythrocytic Plasmodium falciparum antigens and protection from infection.
    John CC; Moormann AM; Pregibon DC; Sumba PO; McHugh MM; Narum DL; Lanar DE; Schluchter MD; Kazura JW
    Am J Trop Med Hyg; 2005 Jul; 73(1):222-8. PubMed ID: 16014863
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.